Paul Blaney

457 total citations
10 papers, 266 citations indexed

About

Paul Blaney is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Paul Blaney has authored 10 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Paul Blaney's work include Chemical Synthesis and Analysis (3 papers), Receptor Mechanisms and Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). Paul Blaney is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Receptor Mechanisms and Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). Paul Blaney collaborates with scholars based in United Kingdom and United States. Paul Blaney's co-authors include Ronald Grigg, Visuvanathar Sridharan, Zoran Ranković, Gurdip Bhalay, Anthony D. Baxter, Mark Thornton‐Pett, Juan Xu, Robert E. Jenkins, Peter Lockey and Nicholas C. Ray and has published in prestigious journals such as Chemical Reviews, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Paul Blaney

10 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Blaney United Kingdom 8 176 161 23 22 17 10 266
Nelson C. F. Yim United States 10 154 0.9× 195 1.2× 11 0.5× 22 1.0× 37 2.2× 16 378
Jack D. Leber United States 11 118 0.7× 187 1.2× 24 1.0× 12 0.5× 33 1.9× 16 435
Cynthia Milligan United States 9 47 0.3× 123 0.8× 20 0.9× 12 0.5× 62 3.6× 14 287
Gregori J. Morriello United States 10 161 0.9× 118 0.7× 8 0.3× 24 1.1× 17 1.0× 16 334
Lise Román Moltzau Norway 13 106 0.6× 228 1.4× 15 0.7× 9 0.4× 41 2.4× 25 426
Andrew J. Kassick United States 11 224 1.3× 160 1.0× 26 1.1× 12 0.5× 35 2.1× 20 434
Jennifer Lafontaine United States 12 218 1.2× 176 1.1× 5 0.2× 10 0.5× 11 0.6× 17 458
Teruki Hamada Japan 9 97 0.6× 126 0.8× 11 0.5× 16 0.7× 43 2.5× 18 318
Tram H. Hoang United States 8 166 0.9× 87 0.5× 9 0.4× 12 0.5× 8 0.5× 11 309
Yorihisa Hoshino Japan 4 173 1.0× 84 0.5× 7 0.3× 14 0.6× 24 1.4× 7 305

Countries citing papers authored by Paul Blaney

Since Specialization
Citations

This map shows the geographic impact of Paul Blaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Blaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Blaney more than expected).

Fields of papers citing papers by Paul Blaney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Blaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Blaney. The network helps show where Paul Blaney may publish in the future.

Co-authorship network of co-authors of Paul Blaney

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Blaney. A scholar is included among the top collaborators of Paul Blaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Blaney. Paul Blaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tozer, Matthew J., Karl R. Gibson, Paul A. Glossop, et al.. (2021). Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure–Activity Relationships and Optimization. Journal of Medicinal Chemistry. 64(6). 3299–3319. 5 indexed citations
2.
Tozer, Matthew J., Karl R. Gibson, Paul A. Glossop, et al.. (2020). Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor. ACS Pharmacology & Translational Science. 3(4). 706–719. 13 indexed citations
3.
Clark, Robin D., Nicholas C. Ray, Karen Williams, et al.. (2008). 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity. Bioorganic & Medicinal Chemistry Letters. 18(4). 1312–1317. 40 indexed citations
4.
Clark, Robin D., Nicholas C. Ray, Paul Blaney, et al.. (2007). 2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(20). 5704–5708. 7 indexed citations
5.
Blaney, Paul, Ronald Grigg, & Visuvanathar Sridharan. (2002). Traceless Solid-Phase Organic Synthesis. Chemical Reviews. 102(7). 2607–2624. 116 indexed citations
6.
Blaney, Paul, Ronald Grigg, Zoran Ranković, Mark Thornton‐Pett, & Juan Xu. (2002). Fused and bridged bi- and tri-cyclic lactams via sequential metallo-azomethine ylide cycloaddition–lactamisation. Tetrahedron. 58(9). 1719–1737. 24 indexed citations
7.
Blaney, Paul, et al.. (2000). Application of Grignard reagents to the synthesis of tertiary methylamines via resin-bound oxyiminium ions. Tetrahedron Letters. 41(34). 6639–6642. 10 indexed citations
8.
Blaney, Paul, et al.. (2000). Solid-phase synthesis of tertiary methylamines via reductive alkylation–fragmentation using a hydroxylamine linker. Tetrahedron Letters. 41(34). 6635–6638. 13 indexed citations
9.
Bhalay, Gurdip, et al.. (1997). Solid-phase synthesis of diverse tetrahydro-1,4-benzodiazepine-2-ones. Tetrahedron Letters. 38(48). 8375–8378. 28 indexed citations
10.
Blaney, Paul, et al.. (1994). A practical synthesis of the enantiomers of hydroxychloroquine. Tetrahedron Asymmetry. 5(9). 1815–1822. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026